Sex hormone, insulin, and insulin-like growth factor signaling in recurrence of high stage endometrial cancer: Results from the NRG Oncology/Gynecologic Oncology Group 210 trial.
Year: 2019
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Gloria S. Huang, Melissa A. Merritt, Alan Hutson, Howard D. Strickler, Mark Einstein, Jurriaan Brouwer-Visser, Nilsa C. Ramirez, Heather A. Lankes, Mona El-Bahrawy, Xiaonan Xue, Herbert Yu, Robert S. Mannel, David M. O'Malley, David Gardner Mutch, Paul Disilvestro, Melissa Ann Geller, Saketh R Guntupalli, Michael J. Birrer, David S. Miller, Marc J. Gunter
Institutions: Yale Cancer Center, Yale University, University of Hawaiʻi at Mānoa, University of Hawaii System, Roswell Park Comprehensive Cancer Center, Albert Einstein College of Medicine, Rutgers New Jersey Medical School, Montefiore Medical Center, Montefiore Einstein Comprehensive Cancer Center, Nationwide Children's Hospital, Imperial College London, University of Hawaii Cancer Center, OU Health Stephenson Cancer Center, The Ohio State University, Washington University in St. Louis, Women & Infants Hospital of Rhode Island, University of Minnesota, University of Colorado Anschutz, University of Alabama at Birmingham, The University of Texas Southwestern Medical Center, Centre international de recherche sur le cancer
Language: English
Subfield: Obstetrics and Gynecology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2947518326